17,261 trials
Measles · Mumps · Rubella
Primary: Number of Participants With Varicella Glycoprotein Enzyme-Linked Immunosorbent Assay (gpELISA) Antibody Titer ≥ 5 gpELISA Units — 198; 299; 253; 303 Participants
Breast Neoplasm
Primary: Number of Participants Who Had a Tumor Response, According to Standard RECIST (Response Evaluation Criteria in Solid Tumors) Criteria — 2; 13; 11 Participants
Diabetes Mellitus · Coronary Artery Disease
Primary: Inhibition of Platelet Aggregation (IPA) 4 Hours After Loading Dose Assessed by Accumetrics VerifyNow™ P2Y12 Assay — 9.4; 9.3; 89.3; 27.7 percent inhibition — p=<0.0001
Kidney Failure
Primary: Serum Creatinine Concentration — 112 umol/L
Carcinoma, Renal Cell
Primary: Number of Subjects With Objective Response — 12; 12; 1; 0 participants
Overactive Bladder · Urinary Incontinence
Primary: Change in Number of Urinary Urge Incontinence Episodes — 32.5; 30.3; 27.8; 28.3 episodes
Asthma
Primary: Mean Heart Rate — 87.6; 84.7; 87.0; 89.3 beats per minute
Community-Acquired Pneumonia (CAP)
Primary: Clinical Cure in the Clinically Evaluable (CE) Population at Test of Cure (TOC) — 34; 37; 32 Participants
Allergic Rhinitis
Primary: Number of Participants With Anatomic Nasal Exam Abnormalities — 3; 2 Participants
Restless Legs Syndrome
Primary: Change From Baseline in Restless Leg Syndrome (RLS) International Restless Leg Group Symptom Severity Rating Scale (IRLS) Total Score at Week 6 — -7.73; -11.83; -11.76…
Refractory Epilepsy
Primary: Change From Baseline in the Mean Number of Daily Seizures at 1 Year. — 9 Number of Seizures — p=<0.02
Skin Structure Infections · Bacterial Skin Diseases · Staphylococcal Skin Infections
Primary: Clinical Response at Test of Cure (TOC) in the Clinically Evaluable (CE) Population — 33; 37; 31 Participants
Asthma
Primary: Change From Baseline in FEV1 (Forced Expiratory Volume; Volume of Air That is Exhaled During the First Second of a Forced Exhalation) — 0.22; 0.17 L (Liter) — p=0.033
Carcinoma, Renal Cell
Primary: Progression Free Survival (PFS) — 386 days
Hypertension
Primary: Change of Sitting Blood Pressure — -10.19; -19.88; -10.13; -4.30 mm Hg